ATHENS, Ga.--(BUSINESS WIRE)--ArunA Bio, Inc., a leader in the development of neural exosomes for the treatment of neurodegenerative diseases, today announced that Dr. Mark A. Sirgo, Chief Executive Officer, will lead a corporate presentation at the 2019 BIO International Convention occurring June 3-6, 2019 in Philadelphia, PA. Dr. Sirgo will provide an update on the company’s emerging pipeline and proprietary neural exosome drug delivery capabilities.
In addition, Dr. Steven Stice, Co-Founder and Chief Scientific Officer, will participate on a panel entitled “Harnessing the Potential of Exosomes”. The panel will explore the full potential of exosomes, and Dr. Stice will discuss the use of exosomes as both a therapeutic and a drug delivery vehicle.
Details of the Corporate Presentation:
Date: Tuesday, June
4, 2019
Time: 11:15-11:30 am ET
Location:
Company Presentation Theater 2, Level 200, Philadelphia Convention Center
Details of the Panel:
Title: Harnessing
the Potential of Exosomes
Date: Tuesday, June 4, 2019
Time:
3:15-4:15 pm ET
Location: 105AB, Level 100, Philadelphia
Convention Center
About ArunA Bio
ArunA Bio is harnessing the natural
abilities of neural exosomes to cross the blood brain barrier and
enhance the body’s anti-inflammatory, self-repair and protective
mechanisms to treat a range of neurodegenerative disorders. ArunA Bio is
also leveraging its proprietary exosomes and manufacturing platform to
create synergistic therapies by enhancing exosomes with RNA,
oligonucleotides, antibodies and small molecules. www.arunabio.com
